Three tumor antigens (CD247, FCGR1A, and TRRAP) correlated with superior prognoses and infiltration of antigen-presenting cells in CHOL were identified using narrow-down analysis, thus promising candidates for mRNA vaccine. Here, TRRAP is linked to neoplasm.